Camp Lejeune cancer lawsuit

The Honoring Our Pact Act And Camp Lejeune Justice Act Now Awaits The President's Signature

Marines and other military veterans may now be able to file lawsuits seeking monetary compensation

Saturday, August 6, 2022 - The impasse blocking the Honoring Our Pact Act and the Camp Lejeune Justice Act has proven short-lived as the US Senate has quickly passed the legislation. The bill had stalled in the Senate as lawmakers argued over spending provisions included in the legislation. Only the signature of the President now stands between veterans with cancer and the potential for real, lump-sum monetary compensation. The Acts will provide military veterans and Marines and their families once stationed at Camp Lejeune enhanced VA health and financial benefits and the right to sue the Federal government. Millions of marines, civilian employees, and their family members that passed through the Camp Lejeune North Carolina area from 1953 to 1987 will no longer be bound by the state's restrictive and some say unconstitutional, two-year statute of limitations and will be able to file suit for lump-sum monetary compensation for cancer and other illnesses they and their family members suffer from. Each Camp Lejeune cancer lawsuit will be tried individually in a court of law and the outcome will stand or fall on the facts of the matter.

The Honoring Our Pact Act will provide military veterans enhanced medical benefits and financial aid by automatically presuming that certain illnesses they and their family members suffer from were caused by exposure to air and water contaminated by toxic burn pit emissions as a result of serving in the military, without having to prove causation. Burn pits were used for decades in the field and home bases to dispose of toxic waste that could not be disposed of elsewhere. The military simply burned it without regard to the toxins that were released into the environment and into the local food chains. The Act rectifies the problem that up until now about three-quarters of all VA cancer and respiratory illness claims by soldiers citing burn pit exposure were denied on the grounds of not having sufficient proof. The surviving family member of those who died from certain illnesses would also be granted enhanced benefits.

The centerpiece of the legislation is the Camp Lejeune Justice Act which presumably will be the most costly component. It is estimated that the HOPA will add about $300 billion to taxpayer bills going forward, however, legal settlements for Camp Lejeune Marines and their families could add hundreds more billions of dollars to the federal deficit. Federal government lawyers will be forced to defend the indefensible actions of the Department of Defense in covering up what they certainly knew about Camp Lejeune water contamination. FedWeek.com wrote "In the early 1980s, the US government discovered dangerous contaminants in the groundwater at Camp Lejeune. Testing found that drinking water sources at Camp Lejeune were contaminated with staggering levels of benzene, trichloroethylene (TCE), tetrachloroethylene, or perchloroethylene (PCE), and vinyl chloride (VC), all of which are known to be carcinogenic and/or harmful to humans." Thousands of Camp Lejeune women suffered miscarriages, stillbirths, and other deadly consequences of drinking the tap water they assumed were safe.

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.